Clonal haematopoiesis and dysregulation of the immune system

R Belizaire, WJ Wong, ML Robinette… - Nature Reviews …, 2023 - nature.com
Age-related diseases are frequently linked to pathological immune dysfunction, including
excessive inflammation, autoreactivity and immunodeficiency. Recent analyses of human …

Tumor hypoxia: From basic knowledge to therapeutic implications

C Liao, X Liu, C Zhang, Q Zhang - Seminars in cancer biology, 2023 - Elsevier
Diminished oxygen availability, termed hypoxia, within solid tumors is one of the most
common characteristics of cancer. Hypoxia shapes the landscape of the tumor …

TET2 guards against unchecked BATF3-induced CAR T cell expansion

N Jain, Z Zhao, J Feucht, R Koche, A Iyer, A Dobrin… - Nature, 2023 - nature.com
Further advances in cell engineering are needed to increase the efficacy of chimeric antigen
receptor (CAR) and other T cell-based therapies,,,–. As T cell differentiation and functional …

2-Oxoglutarate-dependent dioxygenases in cancer

JA Losman, P Koivunen, WG Kaelin Jr - Nature Reviews Cancer, 2020 - nature.com
Oxoglutarate-dependent dioxygenases (2OGDDs) are a superfamily of enzymes that play
diverse roles in many biological processes, including regulation of hypoxia-inducible factor …

T cell receptor‐based cancer immunotherapy: emerging efficacy and pathways of resistance

SS Chandran, CA Klebanoff - Immunological reviews, 2019 - Wiley Online Library
Adoptive cell transfer (ACT) using chimeric antigen receptor (CAR)‐modified T cells can
induce durable remissions in patients with refractory B‐lymphoid cancers. By contrast …

The interplay between DNA and histone methylation: molecular mechanisms and disease implications

Y Li, X Chen, C Lu - EMBO reports, 2021 - embopress.org
Methylation of cytosine in CpG dinucleotides and histone lysine and arginine residues is a
chromatin modification that critically contributes to the regulation of genome integrity …

Clonal hematopoiesis: Mutation-specific adaptation to environmental change

MA Florez, BT Tran, TK Wathan, J DeGregori… - Cell Stem Cell, 2022 - cell.com
Clonal hematopoiesis of indeterminate potential (CHIP) describes a widespread expansion
of genetically variant hematopoietic cells that increases exponentially with age and is …

Cellular and molecular waypoints along the path of T cell exhaustion

X Lan, CC Zebley, B Youngblood - Science immunology, 2023 - science.org
Thirty years of foundational research investigating molecular and cellular mechanisms
promoting T cell exhaustion are now enabling rational design of T cell–based therapies for …

Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy

Y Xu, L Lv, Y Liu, MD Smith, WC Li… - The Journal of …, 2019 - Am Soc Clin Investig
Loss-of-function mutations in genes encoding TET DNA dioxygenase occur frequently in
hematopoietic malignancy, but rarely in solid tumors, which instead commonly have reduced …

Aging drives Tet2+/− clonal hematopoiesis via IL-1 signaling

F Caiado, LV Kovtonyuk, NG Gonullu, J Fullin… - Blood, 2023 - ashpublications.org
Clonal hematopoiesis of indeterminate potential (CHIP), also referred to as aging-related
clonal hematopoiesis, is defined as an asymptomatic clonal expansion of mutant mature …